124 related articles for article (PubMed ID: 33712992)
1. Angiomotin-p130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of Smad2/3 signal pathway.
Li D; Shen Y; Ren H; Wang L; Yang J; Wang Y
J Bioenerg Biomembr; 2021 Jun; 53(3):295-305. PubMed ID: 33712992
[TBL] [Abstract][Full Text] [Related]
2. Repression of linc01555 up-regulates angiomotin-p130 via the microRNA-122-5p/clic1 axis to impact vasculogenic mimicry-mediated chemotherapy resistance in small cell lung cancer.
Li D; Shen Y; Ren H; Wang L; Yang J; Wang Y
Cell Cycle; 2023 Jan; 22(2):255-268. PubMed ID: 36045598
[TBL] [Abstract][Full Text] [Related]
3. Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer.
Yang J; Zhang X; Chen Z; Shen Y; Wang F; Wang Y; Liu Y; Liu P; Yang J
Cell Death Dis; 2019 Feb; 10(3):179. PubMed ID: 30792381
[TBL] [Abstract][Full Text] [Related]
4. Reduced angiomotin p130 expression correlates with poor prognosis in lung adenocarcinoma.
Jang SH; Cho HD; Lee JH; Lee HJ; Hong SA; Cho J; Kim HJ; Oh MH
J Clin Pathol; 2017 Jul; 70(7):625-630. PubMed ID: 27980054
[TBL] [Abstract][Full Text] [Related]
5. CLIC1 knockout inhibits invasion and migration of gastric cancer by upregulating AMOT-p130 expression.
Qiu Y; Mao YT; Zhu JH; Zhao K; Wang JF; Huang JM; Chang GQ; Guan YT; Huang FY; Hu YJ; Chen JQ; Liu JL
Clin Transl Oncol; 2021 Mar; 23(3):514-525. PubMed ID: 32656583
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of expression profiles of some tumor growth-related genes after silencing of pleiotrophin in human small cell lung cancer H446 cells].
Yu Y; Shi MH; Xu X; Zhang ZL; Hu HC
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):405-9. PubMed ID: 20819478
[TBL] [Abstract][Full Text] [Related]
7. Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer.
Hong SA; Son MW; Cho J; Jang SH; Lee HJ; Lee JH; Cho HD; Oh MH; Lee MS
APMIS; 2017 Nov; 125(11):996-1006. PubMed ID: 28885730
[TBL] [Abstract][Full Text] [Related]
8. The Nedd4-like ubiquitin E3 ligases target angiomotin/p130 to ubiquitin-dependent degradation.
Wang C; An J; Zhang P; Xu C; Gao K; Wu D; Wang D; Yu H; Liu JO; Yu L
Biochem J; 2012 Jun; 444(2):279-89. PubMed ID: 22385262
[TBL] [Abstract][Full Text] [Related]
9. Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression.
Hsu YL; Hung JY; Chou SH; Huang MS; Tsai MJ; Lin YS; Chiang SY; Ho YW; Wu CY; Kuo PL
Oncogene; 2015 Jul; 34(31):4056-68. PubMed ID: 25381822
[TBL] [Abstract][Full Text] [Related]
10. Angiomotin Family Members: Oncogenes or Tumor Suppressors?
Lv M; Shen Y; Yang J; Li S; Wang B; Chen Z; Li P; Liu P; Yang J
Int J Biol Sci; 2017; 13(6):772-781. PubMed ID: 28656002
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells.
Ernkvist M; Birot O; Sinha I; Veitonmaki N; Nyström S; Aase K; Holmgren L
Biochim Biophys Acta; 2008 Mar; 1783(3):429-37. PubMed ID: 18164266
[TBL] [Abstract][Full Text] [Related]
12. The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms.
Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Li ZY; Zhang RG; Zhu F; Wu G
Int J Cancer; 2019 May; 144(9):2227-2238. PubMed ID: 30374974
[TBL] [Abstract][Full Text] [Related]
13. Vasculogenic mimicry in small cell lung cancer.
Williamson SC; Metcalf RL; Trapani F; Mohan S; Antonello J; Abbott B; Leong HS; Chester CP; Simms N; Polanski R; Nonaka D; Priest L; Fusi A; Carlsson F; Carlsson A; Hendrix MJ; Seftor RE; Seftor EA; Rothwell DG; Hughes A; Hicks J; Miller C; Kuhn P; Brady G; Simpson KL; Blackhall FH; Dive C
Nat Commun; 2016 Nov; 7():13322. PubMed ID: 27827359
[TBL] [Abstract][Full Text] [Related]
14. AMOT suppresses tumor progression via regulating DNA damage response signaling in diffuse large B-cell lymphoma.
Sang T; Yang J; Liu J; Han Y; Li Y; Zhou X; Wang X
Cancer Gene Ther; 2021 Nov; 28(10-11):1125-1135. PubMed ID: 33414519
[TBL] [Abstract][Full Text] [Related]
15. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype.
Yao L; Zhang D; Zhao X; Sun B; Liu Y; Gu Q; Zhang Y; Zhao X; Che N; Zheng Y; Liu F; Wang Y; Meng J
J Cell Mol Med; 2016 Sep; 20(9):1673-85. PubMed ID: 27240974
[TBL] [Abstract][Full Text] [Related]
16. MMP-2 and MMP-13 affect vasculogenic mimicry formation in large cell lung cancer.
Li Y; Sun B; Zhao X; Wang X; Zhang D; Gu Q; Liu T
J Cell Mol Med; 2017 Dec; 21(12):3741-3751. PubMed ID: 28766880
[TBL] [Abstract][Full Text] [Related]
17. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis.
Yi C; Shen Z; Stemmer-Rachamimov A; Dawany N; Troutman S; Showe LC; Liu Q; Shimono A; Sudol M; Holmgren L; Stanger BZ; Kissil JL
Sci Signal; 2013 Sep; 6(291):ra77. PubMed ID: 24003254
[TBL] [Abstract][Full Text] [Related]
18. Angiomotin promotes breast cancer cell proliferation and invasion.
Lv M; Lv M; Chen L; Qin T; Zhang X; Liu P; Yang J
Oncol Rep; 2015 Apr; 33(4):1938-46. PubMed ID: 25647626
[TBL] [Abstract][Full Text] [Related]
19. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
[TBL] [Abstract][Full Text] [Related]
20. Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway.
Gong W; Sun B; Zhao X; Zhang D; Sun J; Liu T; Gu Q; Dong X; Liu F; Wang Y; Lin X; Li Y
Oncotarget; 2016 Oct; 7(43):70152-70167. PubMed ID: 27659524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
